A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...
Key Takeaways In a small trial, 8 of 16 patients responded well to the mRNA vaccineThe vaccine is personalized, based on each ...
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.